Unfortunately, the clinical effect of drugs that target this protein may only last for a few months (Rudin et al., 2009 ▶) owing to the rapid insurgence of drug-resistant cancer cells carrying mutations in SMO itself (Yauch et al., 2009 ▶). The gene discussed is SMO; the disease is cancer.